Predictive Oncology: Helomics to present initial findings from its analysis of UK 100,000 Genomes Project data towards its goal of building AI-driven predictive models of ovarian cancer

    NEXT STORY
    Rafael Pharmaceuticals Announces Expansion into South Korea of Pivotal Phase 3 Trial of CPI-613® (devimistat) in Patients with Metastatic Pancreatic Cancer
    PREV STORY
    Ontario Liberal Leadership Candidate Announces Plan to Merge Public, Catholic School Boards
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2019

    author_avatar
    NASDAQ Market News

    Oncology Pharma Announces Extension of Letter of Intent with Kalos Therapeutics, Retained an Interim CEO and Approval of Reverse Stock Split

    author_avatar
    NASDAQ Market News

    G1 Therapeutics Presents Additional Phase 2 Data on Trilaciclib in Small Cell Lung Cancer at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

    author_avatar
    NASDAQ Market News